Home  /  Resource Library  /  Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL): a randomized phase 3 trial

Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL): a randomized phase 3 trial

Results of a phase III trial investigating the effectiveness of chemoimmunotherapy for treatment of early stage high risk CLL.